Equitable Trust CO Exact Sciences Corp Transaction History

Equitable Trust CO

  • $1.47 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 21, 2020
SELL
$37.9 - $104.44 $105,589 - $290,969
-2,786 Closed
0 $0
Q4 2019

Feb 18, 2020
BUY
$77.66 - $99.74 $3,883 - $4,987
50 Added 1.83%
2,786 $257,000
Q3 2019

Nov 19, 2019
BUY
$90.37 - $122.49 $247,252 - $335,132
2,736 New
2,736 $247,000

Others Institutions Holding EXAS

# of Institutions
676
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Equitable Trust CO Portfolio

Follow Equitable Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email